Adaptive Biotechnologies Corp Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adaptive Biotechnologies Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2024.
  • Adaptive Biotechnologies Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $44K, a 93.5% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $2.25M, a 98.3% decline from 2022.
  • Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $132M, a 387% increase from 2021.
  • Adaptive Biotechnologies Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $27.1M, a 90.8% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $44K -$628K -93.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $672K -$2.08M -75.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $2.75M -$11.9M -81.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $14.6M +$9.66M +195% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $4.96M +$4.84M +3899% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $124K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.